This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Baldari CT, Lanzavecchia A, Telford JL (2005) Immune subversion by Helicobacter pylori. Trends Immunol 26:199–207. https://doi.org/10.1016/j.it.2005.01.007BaldariCTLanzavecchiaATelfordJL2005Immune subversion by Helicobacter pylori26199207https://doi.org/10.1016/j.it.2005.01.007Search in Google Scholar
Chehelgerdi M, Doosti A (2020) Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: An efficient candidate for Helicobacter pylori DNA vaccine. J Nanobiotechnol 18:63. https://doi.org/10.1186/s12951-020-00618-1ChehelgerdiMDoostiA2020Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: An efficient candidate for Helicobacter pylori DNA vaccine1863https://doi.org/10.1186/s12951-020-00618-1Search in Google Scholar
Choi IK, Sung HJ, Lee JH et al (2012) The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer. Cancer Chemother Pharmacol 70:555–558. https://doi.org/10.1007/s00280-012-1944-5ChoiIKSungHJLeeJH2012The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer70555558https://doi.org/10.1007/s00280-012-1944-5Search in Google Scholar
Fakharian F, Asgari B, Nabavi-Rad A et al (2022) The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis. Front Cell Infect Microbiol 12:953718. https://doi.org/10.3389/fcimb.2022.953718FakharianFAsgariBNabavi-RadA2022The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis12953718https://doi.org/10.3389/fcimb.2022.953718Search in Google Scholar
Ghajari G, Nabiuni M, Amini E (2021) The association between testicular toxicity induced by Li2Co3 and protective effect of Ganoderma lucidum: Alteration of Bax & c-Kit genes expression. Tissue Cell 72:101552. https://doi.org/10.1016/j.tice.2021.101552GhajariGNabiuniMAminiE2021The association between testicular toxicity induced by Li2Co3 and protective effect of Ganoderma lucidum: Alteration of Bax & c-Kit genes expression72101552https://doi.org/10.1016/j.tice.2021.101552Search in Google Scholar
Gupta N, Maurya S, Verma H et al (2019) Unraveling the factors and mechanism involved in persistence: Host-pathogen interactions in Helicobacter pylori. J Cell Biochem 120:18572–18587. https://doi.org/10.1002/jcb.29201GuptaNMauryaSVermaH2019Unraveling the factors and mechanism involved in persistence: Host-pathogen interactions in Helicobacter pylori1201857218587https://doi.org/10.1002/jcb.29201Search in Google Scholar
He LJ, Xie D, Hu PJ et al (2015) Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer. World J Gastroenterol 21:9916–9926. https://doi.org/10.3748/wjg.v21.i34.9916HeLJXieDHuPJ2015Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer2199169926https://doi.org/10.3748/wjg.v21.i34.9916Search in Google Scholar
Kafarski P, Talma M (2018) Recent advances in design of new urease inhibitors: A review. J Adv Res 13:101–112. https://doi.org/10.1016/j.jare.2018.01.007KafarskiPTalmaM2018Recent advances in design of new urease inhibitors: A review13101112https://doi.org/10.1016/j.jare.2018.01.007Search in Google Scholar
Kang SY, Han JH, Ahn MS et al (2012) Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection. Int J Cancer 130:948–958. https://doi.org/10.1002/ijc.26081KangSYHanJHAhnMS2012Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection130948958https://doi.org/10.1002/ijc.26081Search in Google Scholar
Kim HJ, Kim N, Yoon H et al (2016) Comparison between resectable Helicobacter pylori-negative and-positive gastric cancers. Gut Liver 10:212–219. https://doi.org/10.5009/gnl14416KimHJKimNYoonH2016Comparison between resectable Helicobacter pylori-negative and-positive gastric cancers10212219https://doi.org/10.5009/gnl14416Search in Google Scholar
Kolb JM, Ozbek U, Harpaz N (2017) Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer. J Gastrointest Oncol 8:583–588. https://doi.org/10.21037/jgo.2017.01.22KolbJMOzbekUHarpazN2017Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer8583588https://doi.org/10.21037/jgo.2017.01.22Search in Google Scholar
Kusters JG, Van Vliet AH, Kuipers EJ et al (2006) Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19:449–490. https://doi.org/10.1128/CMR.00054-05KustersJGVan VlietAHKuipersEJ2006Pathogenesis of Helicobacter pylori infection19449490https://doi.org/10.1128/CMR.00054-05Search in Google Scholar
Larussa T, Leone I, Suraci E et al (2015) Helicobacter pylori and T helper cells: Mechanisms of immune escape and tolerance. J Immunol Res 2015:981328. https://doi.org/10.1155/2015/981328LarussaTLeoneISuraciE2015Helicobacter pylori and T helper cells: Mechanisms of immune escape and tolerance2015981328https://doi.org/10.1155/2015/981328Search in Google Scholar
Lee WJ, Lin JT, Shun CT et al (1995) Comparison between resectable gastric adenocarcinomas seropositive and seronegative for Helicobacter pylori. Br J Surg 82:802–805. https://doi.org/10.1002/bjs.1800820627LeeWJLinJTShunCT1995Comparison between resectable gastric adenocarcinomas seropositive and seronegative for Helicobacter pylori82802805https://doi.org/10.1002/bjs.1800820627Search in Google Scholar
Li G, Wang Z, Wang Z et al (2013) Gastric cancer patients with Helicobacter pylori infection have a poor prognosis. J Surg Oncol 108:421–426. https://doi.org/10.1002/jso.23417LiGWangZWangZ2013Gastric cancer patients with Helicobacter pylori infection have a poor prognosis108421426https://doi.org/10.1002/jso.23417Search in Google Scholar
Li P, Zhou L, Zhao T et al (2017) Caspase-9: Structure, mechanisms and clinical application. Oncotarget 8:23996–24008. https://doi.org/10.18632/oncotarget.15098LiPZhouLZhaoT2017Caspase-9: Structure, mechanisms and clinical application82399624008https://doi.org/10.18632/oncotarget.15098Search in Google Scholar
Maleki Kakelar H, Barzegari A, Dehghani J et al (2019) Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination. Gastric Cancer 22:23–36. https://doi.org/10.1007/s10120-018-0867-1Maleki KakelarHBarzegariADehghaniJ2019Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination222336https://doi.org/10.1007/s10120-018-0867-1Search in Google Scholar
Malfertheiner P, Megraud F, Rokkas T et al (2022) Management of Helicobacter pylori infection: The Maastricht VI/Florence consensus report. Gut 71:1724–1762. https://doi.org/10.1136/gutjnl-2022-327745MalfertheinerPMegraudFRokkasT2022Management of Helicobacter pylori infection: The Maastricht VI/Florence consensus report7117241762https://doi.org/10.1136/gutjnl-2022-327745Search in Google Scholar
Marrelli D, Pedrazzani C, Berardi A et al (2009) Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer 115:2071–2080. https://doi.org/10.1002/cncr.24253MarrelliDPedrazzaniCBerardiA2009Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer11520712080https://doi.org/10.1002/cncr.24253Search in Google Scholar
Martínez-Becerra F, Castillo-Rojas G, de León SP et al (2012) IgG subclasses against Helicobacter pylori isolates: An important tool for disease characterization. Scand J Immunol 76:26–32. https://doi.org/10.1111/j.1365-3083.2012.02699.xMartínez-BecerraFCastillo-RojasGde LeónSP2012IgG subclasses against Helicobacter pylori isolates: An important tool for disease characterization762632https://doi.org/10.1111/j.1365-3083.2012.02699.xSearch in Google Scholar
Meimarakis G, Winter H, Assmann I et al (2006) Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: A prospective study. Lancet Oncol 7:211–222. https://doi.org/10.1016/S1470-2045(06)70586-1MeimarakisGWinterHAssmannI2006Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: A prospective study7211222https://doi.org/10.1016/S1470-2045(06)70586-1Search in Google Scholar
Mezmale L, Coelho LG, Bordin D et al (2020) Review: Epidemiology of Helicobacter pylori. Helicobacter 25 Suppl 1:e12734. https://doi.org/10.1111/hel.12734MezmaleLCoelhoLGBordinD2020Review: Epidemiology of Helicobacter pylori25Suppl 1e12734https://doi.org/10.1111/hel.12734Search in Google Scholar
Nagaraja V, Eslick GD (2014) Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: A systematic review. World J Gastroenterol 20:14527–14536. https://doi.org/10.3748/wjg.v20.i40.14527NagarajaVEslickGD2014Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: A systematic review201452714536https://doi.org/10.3748/wjg.v20.i40.14527Search in Google Scholar
O’Connor A, Furuta T, Gisbert JP et al (2020) Review – treatment of Helicobacter pylori infection 2020. Helicobacter 25 Suppl 1:e12743. https://doi.org/10.1111/hel.12743O’ConnorAFurutaTGisbertJP2020Review – treatment of Helicobacter pylori infection 202025Suppl 1e12743https://doi.org/10.1111/hel.12743Search in Google Scholar
Park HE, Park S, Nizamutdinov D et al (2022) Antigenic determinant of Helicobacter pylori FlaA for developing serological diagnostic methods in children. Pathogens 11:1544. https://doi.org/10.3390/pathogens11121544ParkHEParkSNizamutdinovD2022Antigenic determinant of Helicobacter pylori FlaA for developing serological diagnostic methods in children111544https://doi.org/10.3390/pathogens11121544Search in Google Scholar
Piri-Gharaghie T, Doosti A, Mirzaei SA (2022a) Fabrication and characterization of pcDNA3. 1 (+) location within chitosan/nanoparticles complexes for enhanced gene delivery. Iran J Biotechnol 20:e3110. https://doi.org/10.30498/ijb.2022.297534.3110Piri-GharaghieTDoostiAMirzaeiSA2022aFabrication and characterization of pcDNA3. 1 (+) location within chitosan/nanoparticles complexes for enhanced gene delivery20e3110https://doi.org/10.30498/ijb.2022.297534.3110Search in Google Scholar
Piri-Gharaghie T, Doosti A, Mirzaei SA (2022b) Identification of antigenic properties of acinetobacter baumannii proteins as novel putative vaccine candidates using reverse vaccinology approach. Appl Biochem Biotechnol 194:4892–4914. https://doi.org/10.1007/s12010-022-03995-5Piri-GharaghieTDoostiAMirzaeiSA2022bIdentification of antigenic properties of acinetobacter baumannii proteins as novel putative vaccine candidates using reverse vaccinology approach19448924914https://doi.org/10.1007/s12010-022-03995-5Search in Google Scholar
Piri-Gharaghie T, Jegargoshe-Shirin N, Saremi-Nouri S et al (2022c) Effects of Imipenem-containing Niosome nanoparticles against high prevalence methicillin-resistant Staphylococcus Epidermidis biofilm formed. Sci Rep 12:5140. https://doi.org/10.1038/s41598-022-09195-9Piri-GharaghieTJegargoshe-ShirinNSaremi-NouriS2022cEffects of Imipenem-containing Niosome nanoparticles against high prevalence methicillin-resistant Staphylococcus Epidermidis biofilm formed125140https://doi.org/10.1038/s41598-022-09195-9Search in Google Scholar
Ranjbar R, Chehelgerdi M (2018) Genotyping and antibiotic resistance properties of Helicobacter pylori strains isolated from human and animal gastric biopsies. Infection and drug resistance. Infect Drug Resist 11:2545–2554. https://doi.org/10.2147/IDR.S187885RanjbarRChehelgerdiM2018Genotyping and antibiotic resistance properties of Helicobacter pylori strains isolated from human and animal gastric biopsies1125452554https://doi.org/10.2147/IDR.S187885Search in Google Scholar
Scopel-Guerra A, Olivera-Severo D, Staniscuaski F et al (2017) The impact of Helicobacter pylori urease upon platelets and consequent contributions to inflammation. Front Microbiol 8:2447. https://doi.org/10.3389/fmicb.2017.02447Scopel-GuerraAOlivera-SeveroDStaniscuaskiF2017The impact of Helicobacter pylori urease upon platelets and consequent contributions to inflammation82447https://doi.org/10.3389/fmicb.2017.02447Search in Google Scholar
Sharndama HC, Mba IE (2022) Helicobacter pylori: An up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol 53:33–50. https://doi.org/10.1007/s42770-021-00675-0SharndamaHCMbaIE2022Helicobacter pylori: An up-to-date overview on the virulence and pathogenesis mechanisms533350https://doi.org/10.1007/s42770-021-00675-0Search in Google Scholar
Shatila M, Thomas AS (2022) Current and future perspectives in the diagnosis and management of Helicobacter pylori infection. J Clin Med 11:5086. https://doi.org/10.3390/jcm11175086ShatilaMThomasAS2022Current and future perspectives in the diagnosis and management of Helicobacter pylori infection115086https://doi.org/10.3390/jcm11175086Search in Google Scholar
Shen Z, Zhou S, Wang Y et al (2010) Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol 136:1585–1595. https://doi.org/10.1007/s00432-010-0816-9ShenZZhouSWangY2010Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer13615851595https://doi.org/10.1007/s00432-010-0816-9Search in Google Scholar
Tempera PJ, Michael M, Tageldin O et al (2022) Gastric cancer due to chronic H. pylori infection: What we know and where we are going. Diseases 10:57. https://doi.org/10.3390/diseases10030057TemperaPJMichaelMTageldinO2022Gastric cancer due to chronic H. pylori infection: What we know and where we are going1057https://doi.org/10.3390/diseases10030057Search in Google Scholar
Tilahun M, Gedefie A, Belayhun C et al (2022) Helicobacter pylori pathogenicity Islands and Giardia lamblia cysteine proteases in role of coinfection and pathogenesis. Infect Drug Resist 15:21. https://doi.org/10.2147/IDR.S346705TilahunMGedefieABelayhunC2022Helicobacter pylori pathogenicity Islands and Giardia lamblia cysteine proteases in role of coinfection and pathogenesis1521https://doi.org/10.2147/IDR.S346705Search in Google Scholar
van den Engel NK, Winter H, Rüttinger D et al (2006) Characterization of immune responses in gastric cancer patients: A possible impact of H. pylori to polarize a tumor-specific type 1 response? Clin Immunol 120:285–296. https://doi.org/10.1016/j.clim.2006.04.566van den EngelNKWinterHRüttingerD2006Characterization of immune responses in gastric cancer patients: A possible impact of H. pylori to polarize a tumor-specific type 1 response?120285296https://doi.org/10.1016/j.clim.2006.04.566Search in Google Scholar
Wang F, Sun G, Zou Y et al (2013) Protective role of Helicobacter pylori infection in prognosis of gastric cancer: Evidence from 2454 patients with gastric cancer. PLoS One 8:e62440. https://doi.org/10.1371/journal.pone.0062440WangFSunGZouY2013Protective role of Helicobacter pylori infection in prognosis of gastric cancer: Evidence from 2454 patients with gastric cancer8e62440https://doi.org/10.1371/journal.pone.0062440Search in Google Scholar
Wang SK, Zhu HF, He BS et al (2007) CagA+ H pylori infection is associated with polarization of T helper cell immune responses in gastric carcinogenesis. World J Gastroenterol 13:2923. https://doi.org/10.3748/wjg.v13.i21.2923WangSKZhuHFHeBS2007CagA+ H pylori infection is associated with polarization of T helper cell immune responses in gastric carcinogenesis132923https://doi.org/10.3748/wjg.v13.i21.2923Search in Google Scholar
Xue LJ, Mao XB, Liu XB et al (2019) Activation of CD3+ T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinoma. Cancer Biol Ther 20:866–876. https://doi.org/10.1080/15384047.2019.1579957XueLJMaoXBLiuXB2019Activation of CD3+ T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinoma20866876https://doi.org/10.1080/15384047.2019.1579957Search in Google Scholar
Zhang J, Zhu Z, Sun Z et al (2014) Survivin gene expression increases gastric cancer cell lymphatic metastasis by upregulating vascular endothelial growth factor-C expression levels. Mol Med Rep 9:600–606. https://doi.org/10.3892/mmr.2013.1858ZhangJZhuZSunZ2014Survivin gene expression increases gastric cancer cell lymphatic metastasis by upregulating vascular endothelial growth factor-C expression levels9600606https://doi.org/10.3892/mmr.2013.1858Search in Google Scholar
Zhang L, Chen X, Ren B et al (2022) Helicobacter pylori in the oral cavity: Current evidence and potential survival strategies. Int J Mol Sci 23:13646. https://doi.org/10.3390/ijms232113646ZhangLChenXRenB2022Helicobacter pylori in the oral cavity: Current evidence and potential survival strategies2313646https://doi.org/10.3390/ijms232113646Search in Google Scholar